Hepatitis C Medicine Manufacturer
Aprazer Healthcare: The Leaders in Hepatitis C Care
Innovative solutions, manufacturing, supplying, and exporting the widest range of Hepatitis C medicines.
Hepatitis C is widely curable when treated timely. With a motive to cure Hepatitis C worldwide, we offer an extensive range of affordable solutions.
State-of-the-Art Manufacturing
Equipped with cutting-edge technology and WHO-GMP approved facilities with periodical audits for quality systems, practices, and documentation.
With a focus on research and development, we explore new treatments, developing patient-centric drugs and next-generation antivirals to offer effective care and safe therapeutics.
Trusted Partners in Manufacturing & Supply
- ✔ Continuous manufacturing: optimized production with continuous processes, reducing manufacturing cost and minimizing wastage.
- ✔ Agile processes: flexibly adapting to changing patient needs and the latest innovations.
- ✔ Scalability: scaled production capacities to meet the demand for Hepatitis C medicines.
The Company’s Leading Drug Candidates
Velakast (Sofosbuvir 400 mg + Velpatasvir 100 mg)
Offers pan-genotypic coverage, treats all types of HCV genotype.
Sofokast Plus (Daclatasvir and Sofosbuvir)
A pan-genotype combination, effective against all types of HCV virus, with strong antiviral effect.
Ledikast (Ledipasvir & Sofosbuvir)
A fixed-dose combination to treat the most resistant genotype 1 with 95% cure rates.
